CClinicalTrials.gg
CompletedNCT00502697BBOUpdated Apr 7, 2017Results posted

Tennessee Connections for Better Birth Outcomes

An interventional study of Targeted Nurse Home Visits and Conventional prenatal/postpartum care in Preterm Birth, sponsored by Vanderbilt University. Completed at 1 site in United States. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-07.

Sponsored by Vanderbilt University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
236
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Women with a history of a prior preterm birth (PTB) have a high probability of a recurrent preterm birth. Some risk factors and health behaviors that contribute to PTB may be amenable to intervention. Home visitation is a promising method to deliver evidence based interventions. We evaluated a system of care designed to reduce preterm births and hospital length of stay in a sample of pregnant women with a history of a PTB. All participants (N = 211) received standard prenatal care. Intervention participants (N = 109) also received home visits by certified nurse-midwives guided by protocols for specific risk factors (e.g., depressive symptoms, abuse, smoking). Data was collected via multiple methods and sources including intervention fidelity assessments. Average age was 27.6 years. Racial breakdown mirrored local demographics. Most women had a partner, a high school education, and Medicaid. Enhanced prenatal care by nurse-midwife home visits may limit some risk factors and shorten intrapartum length of stay for women with a prior PTB. This study contributes to knowledge about evidence-based home visit interventions directed at risk factors associated with PTB.

Read the detailed description

Preterm births (PTBs) are the leading cause of death in infants under the age of one. Tennessee (TN) is one of the lowest ranking states in the US for rates of PTBs (46th) and infant mortality (48th). Costs for neonatal care increase exponentially with decreasing gestational age, and there are lifelong consequences for families and communities. Despite medications and improved diagnostic tools, a 27% increase in PTBs has occurred in the past 20 years. With a history of one PTB, the probability of another PTB is approximately 30%. The risk of having another PTB rises to almost 70% if the woman has a history of more than one PTB. Relationships between a variety of factors (e.g., African American race, smoking, short interval between pregnancies, socio-environmental stressors) likely contribute to TN's high rate of PTBs. Several interventions have been identified to reduce PTBs and improve maternal and infant health indicators but with varying success; administering intramuscular injections of progesterone between 16 and 36 weeks gestation, providing some prenatal care in the home of women with a high risk pregnancy, increasing the interval between pregnancies, and reducing social factors that negatively impact health, such as smoking, substance abuse and stress.

The overall purpose of this study was to determine if a combined medical and biobehavioral intervention would prevent PTBs and reduce healthcare costs in a sample of women who have had a prior PTB. The medical intervention was conventional prenatal and postpartum clinic care. The biobehavioral intervention included certified nurse midwife home visitors who engaged women in an integrated System of Care (SOC) during their prenatal care. Care continued during the first 18 months of the infant's life by maternal-child nurse visitors. Home visits were in addition to regularly scheduled conventional prenatal and postpartum clinic care. Main study questions were:

Is there a difference in: 1) the length of gestational age of infants of high-risk pregnant women who receive the medical intervention and high-risk pregnant women who receive the SOC? 2) in health care costs between women who receive the medical intervention and the SOC? 3) intervals between the current pregnancy and a subsequent pregnancy across groups? and 4) in length of gestational age of current infant with gestational age of index prior preterm birth?

02

Conditions studied

  • Preterm Birth

Browse trials for

Keywords

  • preterm
  • prematurity
  • home visitation
  • system of care
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 236 is above the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Vanderbilt University is the lead sponsor of 508 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Documented history of previous preterm delivery. Defined as delivery from 20 weeks to 36 weeks 6 days gestation.
  • Proven pregnancy
  • Reside in Davidson County, Tennessee (TN) or surrounding county in 90 mile driving radius.
  • Less than 24 weeks gestation at enrollment
  • Will receive prenatal care at a Vnderbilt University Medical Center (VUMC) clinic
  • Willing to accept nurse home visits and be randomly assigned to conventional care or care with home visits
  • Speaks and understands English
  • Between the ages of 18 and 40 years.

Exclusion criteria

Exclusion Criteria:

  • Known fetal anomaly that can not be managed conservatively or fetal demise
  • Maternal medical or obstetrical complications including:

    • Current or scheduled cervical cerclage
    • PROM in current pregnancy prior to enrollment
  • Participation in an antenatal study in which the clinical status or intervention may influence gestational age at delivery
  • Profound mental dysfunction or under guardianship
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
236 participants (actual)

Study arms

  • Experimental
    Targeted Nurse Home Visits

    Advanced practice nurses provide targeted behavioral interventions during home visits. These visits were in addition to regularly scheduled conventional prenatal and postpartum clinic visits. Specific protocols guided nurse interventions related to tobacco use, substance use and misuse, stress management, dental health, maternal infections, perinatal depressive symptoms, family violence, reproductive life plans and continuity of care. Home visits were continued in the postpartum period (through 18 months post-delivery) with a continued focus on risk factors identified during the prenatal period and internatal health care.

    Behavioral: Targeted Nurse Home Visits · Other: Conventional prenatal/postpartum care

  • Other
    Conventional prenatal/postpartum care

    Women assigned to the control arm of the study received conventional prenatal and postpartum clinic care.

    Other: Conventional prenatal/postpartum care

Interventions

  • BehavioralTargeted Nurse Home Visits

    Advanced practice nurses provide targeted behavioral interventions during home visits. These visits were in addition to regularly scheduled conventional prenatal and postpartum clinic care. Specific protocols guided nurse interventions related to tobacco use, substance use and misuse, stress management, dental health, maternal infections, perinatal depressive symptoms, family violence, reproductive life plans and continuity of care. Home visits were continued in the postpartum period (through 18 months post-delivery) with a continued focus on risk factors identified during the prenatal period and internatal health care.

  • OtherConventional prenatal/postpartum care

    Women in this group received conventional prenatal care and postpartum clinic care.

    Also known as: standard medical prenatal and postpartum care

06

What researchers measure

Primary outcomes

  1. Infant Gestational Age

    Infant gestational age was determined by the weeks and days gestation documented in the maternal delivery record.

    Time frame: Time of delivery

Secondary outcomes

  1. Maternal Length of Stay at Delivery

    Number of maternal hospital days associated with delivery

    Time frame: Hospital discharge point following delivery

07

Results

Posted Mar 16, 2016

Participant flow

The sample consisted of pregnant women receiving prenatal care with a (physician or nurse-midwife) at a large regional medical center in the Southeastern U.S. from April, 2007 through January, 2010.

Participant flow — Overall Study
MilestoneIntervention GroupControl Group
Started122114
Completed109102
Not completed1312
Withdrew: Withdrawal by subject31
Withdrew: Disenrolled due to pregnancy loss35
Withdrew: Found not to meet eligibility criteria34
Withdrew: Did not meet assignment criteria42

Outcome measures

PrimaryInfant Gestational Age

Infant gestational age was determined by the weeks and days gestation documented in the maternal delivery record.

Time frame:
Time of delivery
Reported as:
Median · weeks
Infant Gestational Age
weeksIntervention GroupControl Group
Infant Gestational Age38.14 (36.57 to 39.29)38.14 (36.29 to 39.14)
Statistical analysis
  • Intervention Group vs Control Group · Wilcoxon (Mann-Whitney) · p = .64
SecondaryMaternal Length of Stay at Delivery

Number of maternal hospital days associated with delivery

Time frame:
Hospital discharge point following delivery
Reported as:
Median · days
Maternal Length of Stay at Delivery
daysIntervention GroupControl Group
Maternal Length of Stay at Delivery2 (1 to 12)3 (0 to 40)

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Group—0/122 (0%)0/122 (0%)
Control Group—0/114 (0%)0/114 (0%)

Baseline characteristics

We analyzed data for participants who remained in the study for at least four weeks following enrollment. The final sample totaled 211 women: 109 intervention and 102 controls.

Age, Categorical
Age, Categorical(Participants)Treatment GroupControl GroupTotal
<=18 years000
Between 18 and 65 years109102211
>=65 years000
Age, Continuous
Age, Continuous(years)Treatment GroupControl GroupTotal
Mean27.4 ± 5.527.8 ± 5.227.6 ± 5.3
Sex: Female, Male
Sex: Female, Male(Participants)Treatment GroupControl GroupTotal
Female109102211
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Treatment GroupControl GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American413475
White6767134
More than one race000
Unknown or Not Reported112
Region of Enrollment
Region of Enrollment(participants)Treatment GroupControl GroupTotal
United States109102211
Marital Status
Marital Status(participants)Treatment GroupControl GroupTotal
Married or Partnered7875153
Divorced or Separated4812
Never Married271946
Type of insurance
Type of insurance(participants)Treatment GroupControl GroupTotal
Medicaid6462126
Private/Champus443680
None/self pay033
Unknown or not reported112
Level of education in years
Level of education in years(years)Treatment GroupControl GroupTotal
Mean13.2 ± 2.513.4 ± 2.613.3 ± 2.6

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
09

References and documents

Publications

  • Lutenbacher M, Gabbe PT, Karp SM, Dietrich MS, Narrigan D, Carpenter L, Walsh W. Does additional prenatal care in the home improve birth outcomes for women with a prior preterm delivery? A randomized clinical trial. Matern Child Health J. 2014 Jul;18(5):1142-54. doi: 10.1007/s10995-013-1344-4. PubMed 23922160 ↗
  • Karp SM, Howe-Heyman A, Dietrich MS, Lutenbacher M. Breastfeeding initiation in the context of a home intervention to promote better birth outcomes. Breastfeed Med. 2013 Aug;8(4):381-7. doi: 10.1089/bfm.2012.0151. Epub 2013 Mar 13. PubMed 23484671 ↗

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00502697
Lead sponsor
Vanderbilt University
Collaborators
Blue Cross Blue Shield, Nurses for Newborns Foundation
Responsible party
Melanie Lutenbacher (Associate Professor of Nursing and Medicine (General Pediatrics), Vanderbilt University) — Principal investigator
First posted
Jul 18, 2007
Start date
Nov 2006
Primary completion
Dec 2012
Completion
Dec 2012
Results posted
Mar 16, 2016
Last update
Apr 7, 2017

Study contacts

Melanie Lutenbacher, PhD
principal investigator · Vanderbilt University
Patricia Temple, MD, MPH
principal investigator · Ohio State University and Vanderbilt University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion